Keros Therapeutics, Inc. (KROS) — Dilution Risk Analysis
Current Snapshot
Keros Therapeutics, Inc. (KROS) has a DilutionWatch score of 25/10 and is classified as LOW risk. The score date in the source data is 2026-09-15T03:44:17.502508.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 25/10 Source (as of 2026-09-15T03:44:17.502508)
Recent SEC Filings
Recent filing forms in the source payload: 4 9, 3 1.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-03-11 | 0001221590-26-000002 |
| 3 | 2026-03-11 | 0001866219-26-000003 |
| 4 | 2026-03-11 | 0001866219-26-000005 |
| 4 | 2026-02-26 | 0002081359-26-000005 |
| 4 | 2026-02-26 | 0002081460-26-000004 |
| 4 | 2026-02-26 | 0001682068-26-000005 |
| 4 | 2026-02-26 | 0001732369-26-000008 |
| 4 | 2026-02-20 | 0001682068-26-000003 |
| 4 | 2026-02-20 | 0002081460-26-000002 |
| 4 | 2026-02-20 | 0002081359-26-000002 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 999 months | Source |
| Three-year share count growth | -33.82% | Source |
DilutionWatch Analysis
- Risk Level
- LOW (Score: 25/10) Source
- Cash Runway
- 999 months Source
- Share Count Growth (3-Year)
- -33.82% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.